RecruitingMyasthenia Gravis, Generalized
A Phase 2 Study to Evaluate Povetacicept in Adults With Generalized Myasthenia Gravis
Eligible age
18+ yrs
Accepts
All genders
Locations
8 states
Healthy volunteers
No
See if you qualify for this study
Answer a few quick questions about your location and health. Takes about a minute.
About this study
The purpose of this study is to evaluate the pharmacodynamic (PD) effect, safety, and tolerability of Povetacicept in participants with generalized myasthenia gravis (gMG).
Sponsor: Vertex Pharmaceuticals Incorporated
Where it's recruiting
California
Mission Hills
Florida
Boca Raton · Homestead · Jacksonville · Miami
Hawaii
Honolulu
Illinois
O'Fallon
Nevada
Las Vegas
South Carolina
Charleston
Tennessee
Chattanooga
Texas
Houston · Sherman · Waxahachie
Source: ClinicalTrials.gov · NCT07501702 · last updated 2026-09-11